Randomized clinical trial of laparoscopic ultrasonography before laparoscopic colorectal cancer resection. BJS 2017; 104: 1462-1469.
Published: 12th September 2017
Authors: S. B. Ellebæk, C. W. Fristrup, C. Hovendal, N. Qvist, L. Bundgaard, S. Salomon et al.
Intraoperative ultrasonography during open surgery for colorectal cancer may be useful for the detection of unrecognized liver metastases. Laparoscopic ultrasonography (LUS) for the detection of unrecognized liver metastasis has not been studied in a randomized trial. This RCT tested the hypothesis that LUS would change the TNM stage and treatment strategy.
Patients with colorectal cancer and no known metastases were randomized (1 : 1) to laparoscopic examination (control or laparoscopy plus LUS) in three Danish centres. Neither participants nor staff were blinded to the group assignment.
Three hundred patients were randomized, 150 in each group. After randomization, 43 patients were excluded, leaving 128 in the control group and 129 in the LUS group. Intraoperative T and N categories were not altered by LUS, but laparoscopy alone identified previously undetected M1 disease in one patient (0·8 per cent) in the control group and three (2·3 per cent) in the LUS group. In the latter group, LUS suggested that an additional six patients (4·7 per cent) had M1 disease with liver (4) or para‐aortal lymph node (2) metastases. The change in treatment strategy was greater in the LUS than in the control group (7·8 (95 per cent c.i. 3·8 to 13·8) and 0·8 (0 to 4·2) per cent respectively;
Routine LUS during resection of colorectal cancer is not recommended. Registration number: NCT02079389 (
You may also be interested in
Authors: K. Mohkam, O. Farges, E. Vibert, O. Soubrane, R. Adam, F.‐R. Pruvot et al.
Notes: Multi‐institutionally validated prognostic tool
Randomized clinical trial
Randomized clinical trial of hepatic resection versus radiofrequency ablation for early‐stage hepatocellular carcinoma. BJS 2017; 104: 1775-1784.
Authors: K. K. C. Ng, K. S. H. Chok, A. C. Y. Chan, T. T. Cheung, T. C. L. Wong, J. Y. Y. Fung et al.
Notes: Radiofrequency ablation is not superior
Authors: L. Escal, S. Nougaret, B. Guiu, M. M. Bertrand, H. de Forges, R. Tetreau et al.
Notes: Imaging criteria predict surgical difficulty
Meta‐analysis of outcomes following resection of the primary tumour in patients presenting with metastatic colorectal cancer.
Authors: U. Nitsche, C. Stöß, L. Stecher, D. Wilhelm, H. Friess, G. O. Ceyhan et al.
Notes: Selected patients only
Authors: V. Wanjura, E. Szabo, J. Österberg, J. Ottosson, L. Enochsson, G. Sandblom et al.
Notes: Avoid unnecessary surgery
Population‐based study of factors predicting treatment intention in patients with locally recurrent rectal cancer. BJS 2017; 104: 1866-1873.
Authors: K. Westberg, G. Palmer, F. Hjern, C. Nordenvall, H. Johansson, T. Holm et al.
Notes: Defines good selection criteria
Authors: P. Probst, S. Ohmann, U. Klaiber, F. J. Hüttner, A. T. Billeter, A. Ulrich et al.
Notes: Publication bias likely
Outcome after restorative proctocolectomy and ileal pouch–anal anastomosis in children and adults. BJS 2017; 104: 1640-1647.
Authors: K. Diederen, S. S. Sahami, M. M. Tabbers, M. A. Benninga, A. Kindermann, P. J. Tanis et al.
Notes: Comparable in children and adults
Weekend admission and mortality for gastrointestinal disorders across England and Wales. BJS 2017; 104: 1723-1734.
Authors: S. E. Roberts, T. H. Brown, K. Thorne, R. A. Lyons, A. Akbari, D. J. Napier et al.
Notes: Worst for gastrointestinal cancer and liver disease
Randomized clinical trial
Randomized clinical trial of laparoscopic versus open pancreatoduodenectomy for periampullary tumours. BJS 2017; 104: 1443-1450.
Authors: C. Palanivelu, P. Senthilnathan, S. C. Sabnis, N. S. Babu, S. Srivatsan Gurumurthy, N. Anand Vijai et al.
Notes: Shorter stay
Authors: K. J. Roberts